Accessibility Tools
Attention, candidates! The deadline to apply for the selection process for the Master's and PhD programs of the Graduate Program in Clinical Medicine (PPGCM) at the UFRJ School of Medicine is today, Monday, June 9, at 2:00 PM (BRT).
Applications opened on June 3 and must be submitted exclusively via email.
Interested candidates must send their application, along with the required documents as specified in the official call, to Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo. before the deadline.
Check the official calls for more information HERE!
The Federal University of Rio de Janeiro (UFRJ) has risen 70 positions in the global ranking by the Center for World University Rankings (CWUR), reaching 331st place among 21,462 institutions evaluated across 94 countries. UFRJ is now the second-best university in Brazil, behind only USP (ranked 118th worldwide), which leads in Latin America. Notably, UFRJ ranked highest in Brazil for the "quality of education" criterion, placing 504th globally in that category.
Despite these advances, Rector Roberto Medronho emphasized that the university still faces budgetary constraints, which affect its performance. He highlighted the dedication of the academic community in the face of limited resources and criticized the funding disparity compared to state institutions, such as those in São Paulo. In the overall ranking, Harvard leads, followed by MIT, Stanford, Cambridge, and Oxford.
Click HERE to read the full article!
Sources: Conexão UFRJ; G1.
The Faculty of Medicine at the Federal University of Rio de Janeiro (FM/UFRJ) has announced the application period for the selection of candidates for the Graduate Programs in Medical Clinic (PPGCM) for the 2025-2 semester. Interested applicants may submit their applications from June 3, 2025, until 2:00 p.m. on June 9, 2025, by sending them to the email address: Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo.
Access the official Calls for Applications for more information:
Tuberculosis, the world's deadliest infectious disease, was the focus of a study recently published in the British journal The Lancet, one of the most prestigious publications in the field of public health. The research features the authorship of Professor Anete Trajman, a faculty member of the Postgraduate Program in Clinical Medicine (PPGCM) at the UFRJ School of Medicine, along with other international researchers.
The study highlights the severity of tuberculosis, which surpasses COVID-19, malaria, and HIV in terms of mortality. It is transmitted through the air, making everyone susceptible to infection, with higher risk in areas of high incidence. Factors such as malnutrition, immunosuppression, smoking, alcohol consumption, and diabetes increase the likelihood of disease progression.
Although the main symptoms include cough, fever, and weight loss, tuberculosis can be asymptomatic, requiring a thorough diagnostic approach. Early diagnosis can be achieved through sputum tests, preferably with rapid molecular tests, and imaging exams such as chest X-rays.
The standard treatment generally lasts six months but may be extended in cases of drug resistance. The study emphasizes the importance of person-centered care, addressing disease determinants such as malnutrition and smoking, as well as managing comorbidities like diabetes and HIV. Even after treatment, ongoing patient monitoring is essential due to long-term sequelae.
In terms of prevention, the research stresses the need for rifamycin-based treatments and points out the limited efficacy of currently available vaccines. The study also underscores the importance of continued research to develop shorter, safer treatment regimens and simpler, more accurate diagnostic methods—crucial advances toward the eradication of tuberculosis.
The publication of this study in The Lancet represents a major achievement for the UFRJ School of Medicine, reinforcing its contribution to global science and the fight against tuberculosis.
Congratulations to Professor Anete Trajman and the entire team of researchers involved in this important study.
Read the full article HERE.
On April 8, the Professor Rodolpho Paulo Rocco Auditorium, at the Center for Health Sciences (CCS) of UFRJ, hosted the 2025 Inaugural Class of UFRJ's Graduate Programe. The event was attended by Professor Denise Pires de Carvalho, former rector of UFRJ and current president of the Coordination for the Improvement of Higher Education Personnel (Capes), who delivered the lecture "Science, Technology and Innovation as a Driver of Brazilian Development: The Importance of Graduate Studies."
The inaugural class established a strong commitment to research and academic training, signaling a promising start to UFRJ's graduate academic year.
The Coordinator of PPGCM/UFRJ, Prof. Heitor Siffert, attended the Inaugural Class of UFRJ's Graduate Program, reaffirming the PPGCM’s commitment to excellence in scientific training and to building an integrated and participatory academic environment.
